Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06032403Not ApplicableActive Not Recruiting

Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations

Role: collaborator

NCT02047851Not ApplicableTerminated

Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis

Role: collaborator

NCT01356758Completed

Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents

Role: collaborator

NCT01604902Unknown

miRNAs and mRNAs in Psoriasis

Role: collaborator

NCT01834781Not ApplicableCompleted

Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity

Role: collaborator

NCT00606671Completed

Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)

Role: collaborator

All 6 trials loaded